Search

A nuclear emergency is a type of accident that can expose a highly variable number of people to isotopes and radiation [[1]]. It can take time to identify radionuclides deposited in the environment and to measure the dose adsorbed by a given individual (which decides the need for specific treatments), but treatments must be started promptly to avoid target organ contamination and deposition. The radionuclides absorbed by the thyroid could lead to thyroid dysfunction and thyroid cancer. [Extracted from the article]

Deprescribing is an important intervention across different settings in medicine, but the literature supporting such a practice is still conflicting. Therefore, we aimed to capture the breadth of outcomes reported and assess the strength of evidence of the use of deprescribing for health outcomes. Umbrella review of systematic reviews of the use of deprescribing searching in Medline, Scopus, and Web of Science until 01 November 2023. The grading of evidence was carried out using the GRADE for intervention studies, whilst data regarding systematic reviews were reported as narrative findings. Among 456 papers, 12 systematic reviews (six with meta-analysis) for a total of 231 RCTs and 44,193 patients were included. In any setting, deprescribing was able to significantly reduce the number of total and of potentially inappropriate medications (PIMs) in older patients (low certainty of evidence) and to reduce the proportion of participants potentially having several or PIMs (moderate certainty of evidence). In community, supported by a high certainty of evidence, deprescribing was not more effective than standard care in decreasing injurious falls, any falls or number of fallers. In nursing home, deprescribing was associated with a significantly lower PIMs than standard care (very low certainty of evidence). In end-of-life situations, deprescribing significantly reduced mortality rate of approximately 41% (high certainty of evidence). Deprescribing is a promising intervention across different settings and situations, but a notable gap in the literature concerning its effects on substantial outcomes still exists. • deprescribing seems to be an effective intervention to address polypharmacy. • deprescribing was able to reduce the number of (PIMs) in older patients. • In nursing home, deprescribing was associated with less PIMs than standard care. • In end-of-life situations, deprescribing significantly reduced mortality. [ABSTRACT FROM AUTHOR]